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GastrulationThe T-box transcription factor Eomesodermin (Eomes) has been implicated in patterning and morphogenesis
in frog, ﬁsh and mouse. In zebraﬁsh, one of the two Eomes homologs, Eomesa, has been implicated in dorsal-
ventral patterning, epiboly and endoderm speciﬁcation in experiments employing over-expression,
dominant-negative constructs and antisense morpholino oligonucleotides. Here we report for the ﬁrst time
the identiﬁcation and characterization of an Eomesa mutant generated by TILLING. We ﬁnd that Eomesa
has a strictly maternal role in the initiation of epiboly, which involves doming of the yolk cell up into the
overlying blastoderm. By contrast, epiboly progression is normal, demonstrating for the ﬁrst time that epib-
oly initiation is genetically separable from progression. The yolk cell microtubules, which are required for
epiboly, are defective in maternal-zygotic eomesa mutant embryos. In addition, the deep cells of the blasto-
derm are more tightly packed and exhibit more bleb-like protrusions than cells in control embryos. We pos-
tulate that the doming delay may be the consequence both of overly stabilized yolk cell microtubules and
defects in the adhesive properties or motility of deep cells. We also show that Eomesa is required for normal
expression of the endoderm markers sox32, bon and og9x; however it is not essential for endoderm
formation.
© 2011 Elsevier Inc. All rights reserved.Introduction
The T-box transcription factor Eomesodermin (Eomes) has been
implicated in patterning and morphogenesis in frog, ﬁsh and mouse.
In Xenopus, where Eomes was ﬁrst identiﬁed, ectopic expression in
animal caps leads to a concentration-dependent induction of meso-
dermal gene expression, with higher doses inducing expression of
more dorsal mesodermal markers (Ryan et al., 1996). In zebraﬁsh,
there are two eomes genes (a and b) (Takizawa et al., 2007), with
eomesa being the more intensively studied. Over-expression of
Eomesa leads to ectopic expression of dorsal organizer genes and sec-
ondary axes are induced when Eomesa is expressed ventrally (Bruce
et al., 2003). In addition, Eomesa has been shown to play a role in in-
duction of the endoderm gene sox32 (Bjornson et al., 2005). More re-
cent work has also shown that Eomesa acts in combination with the
transcription factor FoxH1 to specify mesendoderm (Slagle et al.,
2011). In the mouse, Eomes mutants completely lack deﬁnitive endo-
derm, while mesodermal patterning is relatively unaffected (Arnold
et al., 2008; Russ et al., 2000)..
rights reserved.Eomes is also important for normal gastrulation movements. Ex-
pression of dominant-negative Eomes constructs in Xenopus embryos
leads to gastrulation arrest (Ryan et al., 1996). In zebraﬁsh embryos, a
similar Eomesa construct produces abnormal epiboly, which is the
ﬁrst coordinated cell movement during development (Bruce et al.,
2005; Lepage and Bruce, 2010; Warga and Kimmel, 1990). Knock-
out of Eomes in the mouse epiblast results in gastrulation defects
due to blocked migration of prospective mesoderm away from the
primitive streak (Arnold et al., 2008; Russ et al., 2000). This migratory
defect appears to be due to the failure to down-regulate expression of
the adhesion molecule E-Cadherin (Arnold et al., 2008).
In zebraﬁsh, unlike Xenopus, Eomesa transcript and protein are
maternally expressed (Bruce et al., 2003; Ryan et al., 1996). Early de-
velopment in zebraﬁsh, as in many animals, relies upon maternal
stores of mRNA and protein that orchestrate development up to the
midblastula transition when zygotic transcription begins (Abrams
and Mullins, 2009). Previous work on Eomesa in zebraﬁsh relied
upon over-expression, morpholino oligonucleotides, and dominant-
negative constructs (Bjornson et al., 2005; Bruce et al., 2005; Bruce
et al., 2003; Slagle et al., 2011). Over-expression and dominant-
negative constructs can have non-speciﬁc effects and morpholinos
have no impact on maternal stores of protein. The caveats of these
tools are reﬂected by the fact that there is confusion in the literature
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(Bjornson et al., 2005; Bruce et al., 2005; Bruce et al., 2003). Thus
our understanding of the role of Eomesa during zebraﬁsh develop-
ment is far from complete. Here we report the phenotype of a loss
of function eomesa allele generated by TILLING (Moens et al., 2008).
Our characterization of embryos lacking either or both maternal and
zygotic Eomesa, as well as the generation of an effective Eomesa anti-
body, has allowed us to gain new insights into Eomesa function. We
ﬁnd that Eomesa has a strictly maternal role in the initiation of epib-
oly, while epiboly progression is normal: demonstrating for the ﬁrst
time that epiboly initiation is genetically separable from progression.




We generated a nonsense allele of eomesa, designated fh105, by
TILLING (Moens et al., 2008). AB and eomesafh105 zebraﬁshweremain-
tained and staged as described (Kimmel et al., 1995). Wild type em-
bryos were obtained from natural matings. Homozygous eomesfh105
mutant embryos were obtained by in vitro fertilization as described
(Westerﬁeld, 1993). Heterozygous eomesfh105 mutant embryos were
obtained by in vitro fertilization using homozygous eomesafh105
sperm and wild type eggs. Maternal eomesa mutant embryos were
obtained by in vitro fertilization using homozygous eomesafh105 eggs
and wild type sperm. Zeomesamutant embryos were obtained by nat-
ural matings of heterozygous individuals and were conﬁrmed by PCR
genotyping (see below). Animals were treated in accordance with
the policies of the University of Toronto Animal Care Committee.
Generation of Eomesa Antibody
The cDNA sequence encoding amino acids 1–661 was cloned into
pETM-14 vector (EMBL Protein Expression and Puriﬁcation Facility,
http://www.helmholtz-muenchen.de/en/pepf/materials/vector-
database/bacterial-expression-vectors/index.html) to express a His-
tag fusion protein in E. coli (BL21 strain DE3). The His-tag protein
was isolated according to the protocol provided by the Bjorkman
Group, Howard Hughes Medical Institute, California Institute of Tech-
nology (http://www.its.caltech.edu/~bjorker/protocols.html), for the
extraction of inclusion bodies (Fig. S1) and then stored in 8 M urea.
Two rabbits were immunized with the His-tag fusion protein,
using a 3-months standard protocol by Eurogentec S.A., Seraing –
Belgium.
In Situ Hybridization
In situ hybridizations were performed as described (Jowett and
Lettice, 1994). Antisense riboprobes for bmp2b (Martinez-Barbera
et al., 1997); bon and sox17 (Alexander and Stainier, 1999); cdh1
(Kane et al., 2005); fgf8a (Reifers et al., 1998); ﬂh (Talbot et al.,
1995); gata5 (Rodaway et al., 1999); gsc (Stachel et al., 1993); lfty1
(Bisgrove et al., 1999), mxtx2 (Hirata et al., 2000); ndr1 (Erter et al.,
1998; Feldman et al., 1998), ndr2 (Rebagliati et al., 1998; Sampath
et al., 1998); ntla (Schulte-Merker et al., 1994); og9x (Poulain and
Lepage, 2002) and sox32 (Alexander et al., 1999) were generated as
described.
Whole-mount Immunohistochemistry
Antibody and phalloidin staining were performed as described
(Bruce et al., 2001; Topczewski and Solnica-Krezel, 1999). Antibodies
were used as follows: anti-Eomesa (1: 500), anti–α–Tubulin (1:500;
Sigma Aldrich), anti-E-Cadherin (1:2500) (Babb and Marrs, 2004)and goat-anti-mouse Alexa 488 secondary (1:1000, Invitrogen). Em-
bryos were mounted in ProLong Gold Antifade reagent (Invitrogen)
in agarose wells on a glass bottom dish (MatTek Corporation) for
analysis on a Zeiss LSM510 confocal microscope or analyzed on a
Leica MZ16F stereomicroscope.
Western Blots
Embryos at sphere stage were dechorionated and blastoderm caps
were manually dissected off the yolk cell. Thirty blastoderm caps
were homogenized in RIPA lysis buffer (Sigma Aldrich) supplemented
with EDTA (1 μM) inhibition, and protease inhibitor cocktail (Roche).
Two to ﬁfteen embryo equivalents were loaded into each lane. Pro-
tein extracts were run on a 10% SDS denaturing protein gel. Gels
were transferred onto nitrocellulose ﬁlter papers using the Bio-Rad
semi-dry transfer apparatus and blocked in 5% milk in PBT (0.1%
Tween −20 in PBS). Blots were incubated in primary antibodies di-
luted in 5% milk overnight at 4 °C, washed in PBT (5 x 10 minutes)
and incubated in secondary antibodies for 1 hr at room temperature.
The following primary antibodies were used: rabbit anti-E-Cadherin
(1:2500) (Babb and Marrs, 2004), anti-Eomesa antibody (1: 750),
anti-α–Tubulin (1: 2000; Sigma Aldrich) and anti-β–Catenin
(1:250; Sigma Aldrich).
PCR Genotyping and RT-PCR
Genotyping for the presence of the eomesfh105 allele was performed
as described (Zebraﬁsh International Resource Center, www.zebraﬁsh.
org). For RT-PCR, RNA was prepared using TRIzol reagent (Invitrogen)
following the manufacturer's instructions. cDNA synthesis was per-
formed using the AfﬁnityScript cDNA synthesis kit (Stratagene). PCR
was performed for 28 cycles using the cycling parameters and primer
sequences from the genotyping assay.
Microinjections and Constructs
Microinjections were performed and RNA for eomesa-VP16,
eomesa-eng, eomesa and gfp were made as described previously
(Bruce et al., 2003). 50 pg of the RNAs were injected per embryo.
Alexa 488 conjugated Histone H1 (Invitrogen) was injected as de-
scribed (Carvalho et al., 2009). The splice blocking morpholino used
to test the speciﬁcity of the Eomesa antibody targets the exon/intron
2 boundary and has the following sequence: GTAATGCTTCATTTCT-
TACCTGCC (GeneTools, LLC). RT-PCR using an exon 2 forward primer
(GACGCGCGTAAAAGTTCTC) and an exon 3 reverse primer
(CTTGATGTTGTTGTCCGCTTTC) was used to conﬁrm the speciﬁcity
of the splice blocking morpholino. In splice blocking morpholino
injected embryos a band of 760 base pairs (bp) instead of the
expected 600 bp was PCR ampliﬁed from cDNA. Sequencing of the
product revealed retention of intron 2, which contains several stop
codons. This corresponded to the truncated protein fragment of ap-
proximately 25 kDa shown in Fig. 1C.
Imaging
Confocal data were acquired using a Zeiss LSM 510 microscope.
Fixed embryos were mounted in wells made in 2% low melt agarose
(Sigma Aldrich) in glass bottom culture dishes (MatTek, Ashland,
MA).
Results
Characterization of the eomesafh105 mutant allele
The eomesafh105 allele was generated by TILLING and it contains a
point mutation that changes a tyrosine at position 100 to a stop codon
Fig. 1. eomesafh105 mutant allele. Schematic of the 661 amino acid full-length Eomesa protein with T-domain in blue. Location of the stop codon in allele fh105 marked by asterisk.
(B) Images of heterozygous (top) and homozygous (bottom) eomesafh105 adult ﬁsh. (C) Control western blot for the anti-Eomesa antibody, lanes as indicated. (D)Western blot of
sphere stage wild type and MZeomesa embryos, lanes as indicated. 15 embryo equivalents loaded per lane. (E) Whole-mount in situ hybridization for eomesa on sphere stage em-
bryos of the indicated genotypes.
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would lack most of the protein, including the critical DNA-binding
T-domain. Homozygous mutant embryos are viable, although they
consistently lack the dorsal ﬁn (Fig. 1B). The lack of dorsal ﬁn is in-
triguing given the known roles other T-box proteins Tbx5 and Tbx4
in forelimb and hindlimb development, respectively (Naiche et al.,
2005). However, this feature of the mutant phenotype has not been
investigated further.
We next wanted to examine Eomesa protein levels to assess
whether the allele is a protein null. Previous reports using two anti-
bodies made against portions of the eomesa sequence yielded contra-
dictory results (Bjornson et al., 2005; Bruce et al., 2003), prompting
us to generate an antibody against the full-length Eomesa protein.
Our antiserum detected a single 75-kDa protein band on immuno-
blots of whole 5 days post-fertilization (dpf) larval lysates (Fig. 1C,
lane 1) and a much stronger band of the same size in adult brain ly-
sates (Fig. 1C, lane 2). The bands are slightly larger than the predicted
72-kDa and may suggest the presence of post-translational modiﬁca-
tions in vivo. To conﬁrm the speciﬁcity of the antibody, embryos were
injected with a splice blocking morpholino targeting the second
exon/intron boundary of eomesa. PCR ampliﬁcation and sequencing
conﬁrmed that morpholino injection resulted in aberrant splicing of
the eomesa transcript (see Materials and Methods). In protein ex-
tracts from morpholino injected embryos a much smaller band was
detected, which corresponded to the truncated protein (Fig. 1C, lane
3) and was absent in uninjected embryos (Fig. 1C, lane 4).
We then performed Western blots on sphere stage wild type and
mutant embryos. Eomesa was greatly reduced in embryos mutant for
both maternal and zygotic Eomesa (MZeomesa) (Fig. 1D) and we did
not detect the predicted truncated protein that would be generated
from the mutant allele (not shown). In addition, no protein was
detected by whole-mount immunohistochemistry of MZeomesa em-
bryos (Fig. S2A). Taken together, the results strongly suggest that
fh105 is a null allele.We also failed to detect eomesa transcript in spherestageMZeomesa andMeomesa embryos bywholemount in situ hybrid-
ization, suggesting that the transcript is degraded (Fig. 1E). In previous
work, we showed that ectopic eomesa leads to transcription from the
endogenous eomesa gene (Bruce et al., 2003). Thus, maternal Eomesa
might be required to activate the expression of zygotic eomesa. eomesa
expression was normal in Zeomesa embryos at sphere stage, which
could indicate activation of zygotic expression by maternal Eomesa or,
alternatively, could represent the maternal transcript alone (Fig. 1E).
At 60% epiboly no nuclear localized Eomesa could be detected in Zeo-
mesa embryos, which was in contrast to control embryos in which nu-
clear staining was clearly visible (Fig. S2B-C). This suggests that
maternal Eomesa levels decline by this stage. In addition, we failed to
detect nuclear localized Eomesa protein in Zeomesa embryos at 1 dpf
(Fig. S2D,E).
Eomesa is nuclear localized during blastula and gastrula stages
An important unanswered question from previous work is the dis-
tribution of Eomesa in the early embryo. Our previous work indicated
that at late blastula and early gastrula stages Eomesa was distributed
throughout the blastoderm, while work by others suggested that ex-
pression was primarily conﬁned to the marginal mesendodermal re-
gion (Bjornson et al., 2005; Bruce et al., 2003). With our improved
antibody, we were able to revisit this issue by performing whole-
mount antibody staining of wild type oocytes and embryos at differ-
ent stages. Eomesa protein was detected around the germinal vesicle
of late stage oocytes and was distributed throughout the cytoplasm of
cleavage stage embryos (data not shown), conﬁrming the presence of
maternal protein. Nuclear localized Eomesa protein was ﬁrst detected
throughout the blastoderm beginning at high stage, with some cyto-
plasmic staining still visible (Fig. 2A). During late blastula and gastru-
la stages, nuclear localized protein was detected throughout the
blastoderm, including the enveloping layer (Figs. 2B-E, S3). Although
cytoplasmic staining could be seen in the yolk syncytial layer (YSL) at
Fig. 2. Eomesa protein distribution. Confocal projections of embryos stained with anti-Eomesa antibody. (A-E) lateral views (F) dorsal view. Stages indicated in lower right. Arrow in
(B) indicates the YSL. (B’) Inset shows YSL of embryo at sphere stage. Arrows indicate unstained YSL-nuclei that are surrounding by Eomesa positive YSL cytoplasm.
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Fig. 2B, B’), Eomesa was not detected in YSL nuclei (Figs. 2B’, S3B),
suggesting that it may not function as a transcription factor in this re-
gion during epiboly initiation. Nuclear localization was also seen in
the telencephalon at 24 hours post-fertilization (hpf, Fig. 2F), consis-
tent with previous work on eomesa transcript localization (Mione
et al., 2001).
Maternal Eomesa is required for the timely initiation of epiboly
Our previous work, using a dominant-negative construct, impli-
cated Eomesa in the control of epiboly initiation (Bruce et al., 2005).
To examine the eomesa mutant phenotype, time matched wild type
(or eomesa heterozygous embryos) and MZeomesa mutant embryos
were observed. Early cleavages proceeded normally in MZeomesa
mutant embryos. MZeomesa embryos reached sphere stage on sched-
ule (Figs. 3A,G) and had normal nuclear morphology (Fig. S4). When
wild type embryos had domed, marking the initiation of epiboly,
MZeomesa mutant embryos were still at sphere stage (Figs. 3B,H).
All MZeomesa mutant embryos examined displayed a 1-hour delay
in doming (n=582).
Interestingly, epiboly progression is not delayed inmutant embryos.
Wild type embryos reached bud stage by 10 hpf, whereas MZeomesa
embryos reached bud stage by 11 hpf. However, MZeomesa embryos
often had awider andmore elongated yolk cell thanwild type embryos
during gastrulation (Fig. 3L). To examine the distribution of yolk syncy-
tial layer nuclei (YSN) and the integrity of the YSL, we injected the YSL
of control and MZeomesa embryos with ﬂuorescent histone (Carvalho
et al., 2009). In MZeomesa embryos epiboly of the YSL was not delayed
and the YSLmaintained its integrity up to 1 dpf (Figs. 4E-I). Crowding or
contraction of the YSN occurred normally inmutant embryos, as seen at
50% epiboly (Fig. 4 compare F to B). YSNwere present inmutant embry-
os although themorphology of some nuclei was abnormal (Fig. 4F) and
clumping of nuclei was visible during epiboly progression (arrow,
Fig. 4G). In wild type embryos, the EVL is positioned ahead of the
deep cells during epiboly (Solnica-Krezel andDriever, 1994).We exam-
ined the relative positioning of EVL and deep cells during epiboly byDIC
microscopy and found that it was normal in mutant embryos during
epiboly progression (Figs. 4J,K).
Taken all together, these results indicate that the epiboly delay ob-
served in MZeomesa embryos is limited to doming, and further dem-
onstrate that the control of epiboly initiation can be separated from
that of epiboly progression. At 24 hpf, an average of 56% of mutantembryos looked wild type (with some batch to batch variation) and
44% displayed a variety of yolk defects with abnormally large yolk ex-
tensions (Figs. 3U-W). Embryos that looked normal at 24 hpf could be
raised to adulthood.
To determine whether the defect in epiboly initiation was due to
loss of either maternal or zygotic Eomesa alone, we examined the
timing of doming in Meomesa and Zeomesa embryos and found that
doming was delayed in Meomesa embryos (100%, n=108, Figs. 3M,
N), but not in Zeomesa embryos (conﬁrmed by PCR genotyping,
n=32, Figs. 3 S,T). Thus, zygotic Eomesa is not required for epiboly
initiation. However, to ensure that embryos lacked all Eomesa func-
tion during early development, we performed most of our analyses
on MZeomesa embryos.
To conﬁrm that the epiboly defect indeed reﬂected the loss of
Eomesa function, we attempted to rescue mutant embryos by inject-
ing eomesa or eomesa-VP16 (previously shown to mimic native
Eomesa function) mRNAs into MZeomesa embryos at the 1-cell
stage (Bruce et al., 2003). Both constructs rescued the doming delay
and yolk morphology, though eomesa-VP16 was more effective, res-
cuing 70% (n=230) of injected MZeomesa embryos (Fig. 3Y), while
injection of gfp RNA had no effect (not shown). Injection of eomesa-
VP16 into the YSL just after its formation was unable to rescue dom-
ing (not shown), further suggesting that Eomesa does not function in
the yolk during doming.
The yolk microtubule cytoskeleton is abnormal in mutant embryos
To examine the doming delay in more detail, we performed time-
lapse microscopy on mutant and wild type embryos. This analysis
revealed the presence of abnormal contractions at the blastoderm/
yolk interface (Supplemental Movie). When doming ﬁnally occurred,
there was considerably less upward movement within the yolk as
compared to control embryos. In addition, the shape of the domed
yolk in mutant embryos did not resemble wild type. In wild type em-
bryos the yolk bulges to the greatest extent at the center of the blas-
toderm and to a lesser extent at the periphery, whereas MZeomesa
mutant embryos displayed a more uniform yolk bulge. These observa-
tions indicated that there might be defects in the yolk cytoskeleton,
which has been previously implicated in driving epiboly movements
(Solnica-Krezel and Driever, 1994; Strähle et al., 1993).
We ﬁrst examined the microtubule cytoskeleton by anti–α–Tubu-
lin antibody staining and confocal microscopy. Previous work showed
that prior to doming there are two microtubule arrays in the yolk cell
Fig. 3. Phenotypes of MZeomesa, Meomesa and Zeomesamutant embryos. Lateral views of live embryos, stages and genotypes as indicated. Doming is delayed in MZeomesa (H) and
Meomesa (N) but not Zeomesa embryos (T). (X, Y) Injection of eomesa-VP16 rescues the timing of epiboly initiation.
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yolk syncytial nuclei and a second array, implicated in epiboly, is orga-
nized longitudinally along the animal-vegetal axis (Solnica-Krezel and
Driever, 1994). Epiboly is delayed when microtubules are disrupted
using U.V. light or treatment with either the microtubule depolymer-
izing drug nocodazole or the stabilizing drug taxol (Solnica-Krezel
and Driever, 1994; Strähle and Jesuthasan, 1993). In MZeomesa em-
bryos microtubules were overtly normal in deep and EVL cells at allstages. At high stage, longitudinal microtubule arrays in the yolk
were visible in both wild type and MZeomesa embryos (arrows,
Figs. 5A,A’). While the microtubules surrounding the yolk syncytial
nuclei were normal, the longitudinally organized microtubules
appeared to be more dense in MZeomesa embryos and spherical
structures were often visible which did not co-stain with nuclear
markers (arrowheads, Fig. 5A’ and not shown). These spherical
structures were also visible as early as cleavage stages.
Fig. 4. Epiboly progression is normal in MZeomesa embryos. (A-I) Overlays of ﬂuorescent and brighﬁeld images of control (A-D) and MZeomesa (E-I) embryos injected into the YSL
with ﬂuorescent histone to highlight the YSN. Stages as indicated. (F) Arrowhead and arrow indicate abnormally large and small nuclei, respectively. (G) Arrow indicates cluster of
clumped nuclei not visible in the control embryo in (C). Wild type (H) and abnormal looking (I) MZeomesa embryos at 1 dpf have intact YSLs (J,K) DIC images of the margin of 60%
epiboly control (J) and MZeomesa (K) embryo. Arrowhead indicates deep cell margin, arrow indicates EVL margin.
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bule array. Instead, a dense and disorganized web of microtubules
covered the yolk surface (Figs. 5B,B’). In some sphere stage mutant
embryos, microtubules were abnormally bundled, leaving large re-
gions of the yolk devoid of Tubulin (not shown). By dome stage,
100% of MZeomesa embryos examined had abnormally bundled yolk
microtubules, with large regions of the yolk lacking Tubulin staining
(Figs. 5C,C’). The severity of the microtubule defects at dome stage,
coupled with the lack of delay in epiboly progression, led us to exam-
ine the microtubules at 75% epiboly. Although the spherical structures
were still visible, most embryos no longer had large regions devoid of
Tubulin staining (Figs. 5D,D’, no voids in 22/30 embryos). These re-
sults suggest that microtubule organization is restored at later stages,
consistent with the lack of delay in epiboly progression.
Injection of eomesa-VP16 RNA into 1-cell stage MZeomesa embry-
os was able to partially rescue the microtubule defects in addition to
rescuing the timing of epiboly initiation (Fig. S5). Although spherical
structures were still visible in the yolk of eomesa-VP16 RNA injected
MZeomesa embryos, the microtubules were more organized and
void regions were no longer present. Thus, there was a correlation be-
tween the rescue of doming and yolk cell microtubule morphology.The yolk cell actin cytoskeleton is normal in MZeomesa embryos
The actin cytoskeleton has been implicated primarily in epiboly pro-
gression (Cheng et al., 2004; Köppen et al., 2006; Zalik et al., 1999). We
examined actin inwild type andmutant embryos by phalloidin staining
and confocal microscopy. The actin cytoskeleton of deep cells appeared
to be normal (not shown). In the yolk cell at sphere and dome stages,
actin at the vegetal pole appeared to be more dense (Figs. 6A-B’).
Actin at the base of the yolk has been postulated to play a role in main-
taining the integrity of the yolk cell (Cheng et al., 2004). In contrast to
what we observed for microtubules, we did not detect abnormal actin
cables or regions of the yolk devoid of actin. Consistent with the obser-
vation that epiboly progression is unaffected in mutant embryos, the
marginal actin band, which is critical for progression and closure ofthe blastopore (Cheng et al., 2004; Köppen et al., 2006), was normal
in mutant embryos (arrowhead, Figs. 6C,C’).
Cellular morphology is altered in mutant embryos
As Eomesa is expressed in the deep cells of the blastoderm, we
were interested in examining these cells for possible cell autonomous
defects. In the mouse, it was shown that mesodermal migration
through the primitive streak is blocked in Eomes mutant embryos
due to a failure to down regulate the cell adhesion molecule
E-Cadherin (Cdh1) (Arnold et al., 2008). Thus, we were interested
in examining whether Cdh1 was upregulated in MZeomesa mutant
embryos, as this might contribute to the doming delay. If Eomesa
were to negatively regulate cdh1 expression, this regulation would
presumably be indirect, as Eomesa appears to be a transcriptional ac-
tivator (Bjornson et al., 2005; Bruce et al., 2003). Confocal imaging of
sphere stage embryos stained with Cdh1 and β-Catenin antibodies
revealed that mutant cells appeared to be in greater contact with
neighboring cells, with less space in between them when compared
to wild type cells (Figs. 7A-D). However, Western blot analyses did
not reveal obvious increases in the levels of either protein (Fig. 7E).
In addition, in situ hybridization for cdh1 expression at sphere
stage did not reveal any obvious changes in expression in MZeomesa
embryos when compared to controls (Fig. 7F). As a change in global
expression levels could be difﬁcult to detect, we also injected
eomesa-eng and eomesa-VP16 RNAs into 1 cell at the 8-cell stage to
produce a localized region of reduced or enhanced Eomesa function,
respectively. If Eomesa is required to down-regulate cdh1 expression,
we would expect to see a region of increased cdh1 expression in en-
grailed construct injected embryos, while cdh1 expression should be
reduced in a localized region in eomesa-VP16 injected embryos. How-
ever, in both cases, no changes in cdh1 expression were observed
(Fig. 7F), thus Eomesa does not appear to regulate cdh1 expression.
Using DIC microscopy on live embryos, we observed that deep
cells in mutant embryos at sphere stage exhibited more blebs than
wild type cells and that there was less space between cells (Fig. 7G),
consistent with the analysis of ﬁxed tissue. Although cellular
Fig. 5. Yolk cell microtubules are altered in MZeomesa embryos. Confocal projections of
lateral views of wild type (A-D) and MZeomesa (A’-D’) embryos stained for Tubulin.
(A, A’) High stage, (B, B’) sphere stage (C, C’) dome stage, (D, D’) 75% epiboly. (A, A’)
Arrows indicate longitudinal microtubule arrays. Arrowheads indicate spherical struc-
tures in MZeomesa embryo. (D, D’) arrows indicate blastoderm-yolk cell boundary.
Fig. 6. The actin cytoskeleton is normal is MZeomesa embryos. Confocal projections of
lateral views of phalloidin stained embryos. (A-C) wild type and (A’-C’) MZeomesa em-
bryos. (A, A’) sphere stage (B, B’) dome stage, (C, C’) close up of marginal region at 75%
epiboly, arrowheads indicate actin band in the YSL.
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and whether it plays a role in the doming delay is currently unclear,
but is suggestive of alterations in cell-cell adhesion and motility.
Expression of endoderm genes is disrupted in eomesa mutant embryos
Eomesa has been implicated in mesoderm and endoderm forma-
tion and patterning in several species (Arnold et al., 2008; Bjornson
et al., 2005; Bruce et al., 2003; Ryan et al., 1996; Slagle et al., 2011).
In zebraﬁsh, Eomesa was shown to be able to directly regulate tran-
scription of the endoderm speciﬁcation gene sox32, while murine
Eomes is essential for deﬁnitive endoderm formation (Arnold et al.,
2008; Bjornson et al., 2005). In addition, the transcription factor
mxtx2, which we previously identiﬁed as a putative downstream tar-
get of Eomesa (Bruce et al., 2005), has recently been shown to act up-
stream of the Nodal related factor ndr2 and to be important for
expression of sox32 in the YSL (Hong et al., 2011).
We ﬁrst examined the expression of the transcription factor
mxtx2. At sphere stage, mxtx2 is expressed in marginal cells and the
YSL, while at dome stage expression is limited to the YSL (Hirata
et al., 2000). In MZeomesa embryos, expression of mxtx2 was delayedand reduced. When MZeomesa embryos ﬁrst reached sphere stage, no
mxtx2 expression was detected, while 40 minutes later, when mutant
embryos were still at sphere stage mxtx2 expression was detected on
one side of the YSL (Figs. 8A-A”). At dome stage,mxtx2was expressed
robustly in the YSL of wild type embryos, while in mutant embryos
mxtx2 was expressed dorsally (as revealed by double in situ with
the dorsal marker goosecoid, gsc) and at much lower levels in the
rest of the YSL (Figs. 8B, B’). This suggests that Eomesa might be in-
volved in activating mxtx2 expression particularly in ventral-lateral
regions. As Mxtx2 has been proposed to act upstream of ndr2, we
next examined the expression of nodal related genes.
Two nodal-like factors ndr1 and ndr2 are expressed in the early
zebraﬁsh embryo (Feldman et al., 1998; Sampath et al., 1998). In
MZeomesa embryos dorsal expression of ndr1 at sphere stage was
normal (arrows, Figs. 8C, C’). At 40% epiboly, most mutant embryos
had normal ndr1 expression, while a minority lacked expression in a
portion of the blastodermmargin (2/18, 11%, Figs. 8D-D”). Expression
of ndr2 was mostly normal at 40% epiboly with 7% (3/41) of embryos
displaying slightly patchy or reduced expression (Figs. 8E, E’) similar
to ndr1 (D”). By contrast, expression of the nodal antagonist lefty1
(lft1) was normal (Figs. 8F, F’). Thus, expression of Nodal-related fac-
tors was only slightly affected in MZeomesa embryos.
We next examined the expression of the endodermal marker
sox32. In wild type embryos at 40% epiboly, sox32 is expressed in a
subset of marginal cells and in the YSL (Dickmeis et al., 2001). In
MZeomesamutant embryos at 40% epiboly, sox32 expression was res-
tricted to the dorsal YSL and marginal cells and was absent ventrally
(n=50, Figs. 8G-H’). At 75% epiboly, the number of sox32 expressing
endoderm precursors cells was also reduced in mutant embryos
(Figs. 8I,I’). Surprisingly, at the same stage, sox17, an endodermmark-
er downstream of sox32, was expressed relatively normally in mutant
Fig. 7. Cell morphology is altered in MZeomesa embryos. (A-D) Confocal images of embryos at sphere stage stained for Cdh1 (A,B) and β-Catenin (C,D). (E) Western blot of wild type
(lane 1) and MZeomesa mutant embryo (lane 2) sphere stage extracts. Levels of Cdh1 and β-Catenin are not obviously altered in mutant embryos. (F) Normal cdh1 expression in
sphere stage wild type, MZeomesa, eomesa-eng and eomesa-VP16 injected wild type embryos, as indicated. (G) Live DIC images of wild type and MZeomesa embryos at sphere stage.
Mutant cells are more tightly packed and exhibit more blebs then wild type cells. Orange highlights selected cell morphologies, purple highlights intercellular space.
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erage of 330 sox17 positive endodermal cells in wild type embryos
(n=4) and 275 sox17 positive cells in MZeomesa mutant embryos
(n=10). The dorsal forerunner cells, which express a number of en-
doderm genes and give rise to Kupffer's vesicle, were often observed
in separate clumps, rather than in a single cluster, as seen in wild type
embryos (arrowheads, Figs. 8J,J’).
Due to the abnormal expression of sox32, we also examined the ex-
pression of zygotic transcription factors acting downstream of Nodal
signaling and upstream of sox32 and sox17. In zebraﬁsh, the major
transcriptional transducers of Nodal signals that are critical for endo-
derm formation are Bon and Gata5 (Kikuchi et al., 2000; Reiter et al.,
1999; Reiter et al., 2001). A third transcription factor, Og9x, acts par-
tially redundantly with Bon (Poulain and Lepage, 2002). Expression
of gata5 in the blastodermmargin was normal in most mutant embry-
os, with 22% showing reduced expression (n=41,Figs. 8K-K”). Ex-
pression of bon was reduced in a portion of the margin in all mutant
embryos examined (Figs. 8L,L’, n=20), while expression of og9x was
nearly absent in all mutant embryos examined (Figs. 8M,M’, n=32).
We also examined expression of pou5f1 as maternal-zygotic mutant
embryos for pou5f1 (spiel ohne grenzen, MZspg) have epiboly and en-
doderm defects (Lachnit et al., 2008; Reim and Brand, 2006). Expres-
sion at sphere stage was normal in MZeomesa embryos (Figs. 8N,N’).
Despite defects in endodermal gene expression, MZeomesa em-
bryos contained a gut tube at 24 hpf, which stained for foxA2
(n=24, Fig. S5). Taken together, and consistent with other ﬁndings
(Bjornson et al., 2005; Slagle et al., 2011), our results suggest that
Eomesa contributes to the expression of endoderm genes but that
other factors can compensate for its absence such that endoderm for-
mation occurs in most mutant embryos.
Expression of mesodermal markers is normal in MZeomesa embryos
We previously showed that ectopic expression of Eomesa ventral-
ly was sufﬁcient to induce expression of the dorsal mesodermal genes
goosecoid (gsc) and ﬂoating head (ﬂh), often leading to the formation
of an ectopic organizer and a secondary axis (Bruce et al., 2003). Wewere thus interested in examining the expression of mesodermal
genes in MZeomesa embryos.
Expression of the dorsal markers gsc and ﬂhwas normal in mutant
embryos (Figs. 9A-B’). The pan-mesodermal marker no tail a (ntla)
was expressed normally throughout the margin at 50% epiboly in mu-
tant embryos; however, it was expressed in fewer cell tiers along the
animal-vegetal axis (Figs. 9C-C”’), which is characteristic of reduced
Nodal signaling (Gritsman et al., 2000). Expression of the ventral
marker bmp2b was normal in most embryos (Figs. 9D-D’), with
some showing a slight reduction in expression (not shown). Expres-
sion of fgf8awas normal in mutant embryos (Figs. 9E,E’). Thus, meso-
dermal patterning was generally unaffected in MZeomesa embryos.
Discussion
Here, with the identiﬁcation of the ﬁrst described eomesa muta-
tion, we are able to extend previous work using eomesa dominant
negative constructs and morpholinos and to begin to clarify the role
of Eomesa during zebraﬁsh development. We show that MZeomesa
mutant embryos have delayed epiboly initiation and defects in endo-
dermal gene expression. Eomesa appears to mediate aspects of mor-
phogenesis and endoderm speciﬁcation in both zebraﬁsh and
mouse, suggesting that these activities represent the ancestral func-
tions of this T-box gene.
Eomesa genetically separates epiboly initiation and progression
Embryos lacking the maternal supply of Eomesa have delayed
epiboly initiation, while the timing of epiboly progression is normal.
Previous work from many groups has shown that delays in epiboly
initiation invariably lead to delays in epiboly progression, indicating
that these events are coordinated. However, the extent to which ini-
tiation and progression are linked and whether the same molecular
mechanisms govern these two phases of epiboly has remained
unclear (Lepage and Bruce, 2010).
A small number of other maternal mutants have been described
that display epiboly initiation defects. MZspg/pou5f1mutant embryos
Fig. 8. Expression of endodermmarkers is reduced in MZeomesa embryos. (A-C’, G, G’, I-J’) lateral views, (D-F’, H, H’, K-M’) animal pole views of embryos stained by whole mount in
situ hybridzation. (A-B’) mxtx2 expression at sphere (A-A”) and dome stage. (B’) gsc in red marks dorsal. (C-D”) ndr1 expression at sphere (arrow, C,C’) and 40% epiboly (D-D”).
(E, E’) ndr2 expression at 40% epiboly. (F,F’) lft1 expression at 40% epiboly (G-H’) sox32 expression at 40% epiboly, (H’) gsc in red marks dorsal. sox32 expression (I,I’) and sox17
expression (J,J’) at 75% epiboly. Arrowheads indicate dorsal forerunner cells. (K-K”) gata5 expression at 40% epiboly. (L,L’) bon expression at 40% epiboly (M,M’) og9x expression
at 40% epiboly. (N.N’) pou5f1 at oblong/sphere. Genotypes indicated in lower left, probe in upper right and percentages of embryos that exhibited given phenotype shown in
lower right where appropriate.
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Fig. 9. Expression of mesodermal markers is normal in MZeomesa embryos. (A-C’, E, E’) animal pole views (C-C”, D, D’) lateral views. Genotypes and markers as indicated in upper
right.
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2008). screeching halt mutant embryos arrest at sphere stage, and
therefore do not undergo any morphogenetic movements (Wagner
et al., 2004). MZpoky embryoswhich carry amutation in the conserved
helix-loop-helix ubiquitous kinase gene, are delayed in epiboly due to
the failure to properly differentiate the EVL (Fukazawa et al., 2010).
Mutation of the maternal-effect gene mission impossible (mis) encod-
ing the helicase Dhx16, results in embryos with defects in epiboly, in-
volution and convergent extension (Putiri and Pelegri, 2011). Thus,
the eomesamutation is unique in that it speciﬁcally affects doming, re-
vealing for the ﬁrst time that aspects of epiboly initiation are geneti-
cally separable from epiboly progression and that distinct molecular
mechanismsmay govern each phase. There appears to be considerable
redundancy in the mechanisms that control epiboly, which presum-
ably explains why MZeomesamutant embryos do eventually dome.
The cellular and molecular basis of the doming delay
Cells in the early embryo ﬁrst become motile and exhibit blebs
around the midblastula transition (Kane and Kimmel, 1993). At this
stage, cell movement is random (Kane and Kimmel, 1993). Doming
occurs shortly afterwards when the yolk cell bulges upwards into
the overlying blastoderm. Deep cells move outward along radial tra-
jectories, resulting in the thinning of the blastoderm and an increase
in its surface area, thereby initiating epiboly (Warga and Kimmel,
1990). Extensive cell mixing occurs during this process but there
are indications that the mixing is not entirely random, and marginal
cells intercalate considerably less than central cells (Wilson et al.,
1993). The current view is that radial intercalation of deep cells in re-
sponse to the yolk cell doming is passive, although this has not been
tested experimentally. Thus, it is not clear whether there is an active
component to the movement and whether cells use blebs for direc-
tional movement at these early stages.
We observed that cells in MZeomesa embryos at sphere stage ap-
pear more tightly packed and exhibit more blebs than wild type
cells. The increase in cell-cell contact, which might reﬂect increased
adhesion, is not accompanied by obvious changes in E-Cadherinlevels. As this change in cell morphology is the most obvious pheno-
type in the blastoderm of mutant embryos, we hypothesize that it is a
factor in the doming delay. There is ample evidence in zebraﬁsh that
blebbing can play a role in directional migration and recent work has
shown that excessive blebbing disrupts this process (Blaser et al.,
2006; Diz-Munoz et al., 2010; Row et al., 2011; Weiser et al., 2009).
In embryos carrying a mutation in another T-box gene, spadetail/
tbx16, mesodermal cells exhibit increased blebbing behavior follow-
ing involution and lose their ability to migrate directionally (Row
et al., 2011). tbx16 mutant cells are also more adhesive, though this
is not the result of changes in either E- or N-Cadherin levels (Row
et al., 2011). Although the excessive blebbing that we observed in
MZeomesa embryos occurs at an earlier developmental stage than in
the tbx16 mutant, the work raises the possibility that the increased
blebbing behavior and potentially increased cell-cell adhesion might
contribute to the doming delay and is a focus of our on-going work.
Of the epiboly mutants identiﬁed, MZeomesa mutant embryos
most closely resemble MZspg embryos. In MZspg mutant embryos,
epiboly initiation and progression are delayed, and deep cell adhesion
is altered without obvious changes in E-Cadherin expression (Lachnit
et al., 2008). In the yolk, abnormal microtubule bundles are apparent
starting at 50% epiboly and there are similar defects in actin organiza-
tion (Lachnit et al., 2008). In MZeomesa embryos, abnormal bundling
of yolk cell micrtubules is visible as early as sphere stage, while actin
organization is normal. The microtubule defects in both MZspg and
MZeomesa embryos resemble those observed in embryos treated
with the microtubule stabilizing drug taxol, which also causes epiboly
delay (Solnica-Krezel and Driever, 1994). Thus, Pouf51 and Eomesa
may act redundantly to inﬂuence the regulation of microtubule dy-
namics in the yolk, with Eomesa having an earlier role. This redun-
dancy could explain the remarkable recovery yolk cell microtubules
in MZeomesa embryos during epiboly progression.
We previously showed that over-expression of Eomesa induces
ectopic expression of the zygotic transcription factor mxtx2. Work
by us and others demonstrated that mxtx2 morphants have delayed
epiboly progression, often resulting in yolk cell lysis, while doming
is normal (Bruce et al., 2005; Wilkins et al., 2008). Mxtx2 functions
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the marginal actin band that drives epiboly progression (Wilkins
et al., 2008). Given the differences in the epiboly defects observed in
MZeomesa mutant embryos and mxtx2 morphants, it is unlikely that
the reduced expression of mxtx2 we observed in MZeomesa mutants
accounts for the doming delay.
Eomesa was not detected in YSL nuclei at sphere and dome stages,
indicating that its affects on the yolk cell doming may be non cell-
autonomous. This is consistent with the fact that YSL injection of
eomesa-VP16 RNA was unable to rescue doming. We note that this
work is in keeping with our previous studies showing that Eomesa
has other non-cell autonomous affects (Bruce et al., 2005; Bruce
et al., 2003), and further suggests that Eomesa may regulate the ex-
pression or activity of an as yet unidentiﬁed signaling molecule(s)
that acts on the yolk. Additional work is required to clarify the func-
tion of Eomesa in the yolk.
In MZeomesa embryos microtubules appear to be more dense than
in wild type embryos, suggesting a failure in the dynamic regulation
of microtubules that is required for epiboly to proceed normally. We
postulate that the doming delay may be the result both of overly sta-
bilized yolk cell microtubules and defects in the adhesive properties
or motility of deep cells. Eomesa is also expressed in the EVL where
it may also function in epiboly, as recent work has shown that both
the differentiation of the EVL and its proper attachment to the YSL
are essential for normal epiboly initiation (Fukazawa et al., 2010;
Sabel et al., 2009; Siddiqui et al., 2010).
Reconciling the role of Eomesa in mesendoderm formation
Sox32 is absolutely required for expression of sox17 and, in turn,
for endoderm formation (Alexander et al., 1999). Expression of
sox32 is reduced but not eliminated in MZeomesa mutant embryos.
Speciﬁcally, sox32 expression is relatively normal on the dorsal side
of the embryo, from where the majority of the endoderm arises
(Warga and Nusslein-Volhard, 1999). Previous work indicates that
Bon and Gata5 interact both with Nodal activated Smads and sepa-
rately with Eomesa to induce sox32 expression (Bjornson et al.,
2005; Germain et al., 2000; Kunwar et al., 2003). Thus, it seems likely
that sox32 expression in MZeomesa results from the remaining ex-
pression of Gata5 and Bon. MZspg mutant embryos express sox32
but fail to express sox17 and completely lack endoderm (Reim et al.,
2004). Pou5f1 and Sox32 and have been shown to act together to ac-
tivate sox17 expression (Reim et al., 2004). pou5f1 expression is nor-
mal in MZeomesa embryos. Thus, we postulate that in MZeomesa
embryos the remaining Sox32 in combination with Pou5F1 is sufﬁ-
cient to activate sox17 and in turn lead to endoderm formation.
Recent work on the midway/foxh1 (mid) mutant suggested that
Eomesa and FoxH1 act combinatorially downstream of Nodal signal-
ing to pattern the mesendoderm (Slagle et al., 2011). Injection of a
dominant negative eomesa-eng construct (Bruce et al., 2003) into
MZmid mutant embryos phenocopies MZoep embryos (Slagle et al.,
2011) which lack all Nodal signaling. This ﬁnding suggests that to-
gether FoxH1 and Eomesa can fully account for Nodal-dependent
mesendodermal patterning. However, the phenotype of MZeomesa
mutant embryos is milder than would be expected based upon this
work. These contradictory results are likely due to the inherent differ-
ences between a loss of function mutation and a dominant-negative
construct.
Similar to MZeomesa mutant embryos, Slagle and co-workers ob-
served that injection of eomesa-eng into wild type embryos had little
to no effect on expression of the dorsal markers ﬂh, ntl (Slagle et al.,
2011). They also demonstrated that FoxH1 plays a more important
role in axial mesoderm patterning than Eomesa, which likely is why
dorsal patterning is normal in MZeomesa mutant embryos. The au-
thors also observed a complete loss of bon expression in eomesa-eng
injected wild type embryos (Slagle et al., 2011), while we saw aconsistent reduction in but not complete loss of bon in MZeomesa em-
bryos. One possibility is that the fh105 allele is not a null, but our data
convincingly show that little or no Eomesa protein is present in
MZeomesa embryos. The more likely explanation is that the eomesa-
eng construct, consisting of the Eomesa T-domain fused to the Dro-
sophila engrailed repressor, has more potent affects than the loss of
function allele. Genes that Eomesa and other transcription factors
(for example FoxH1) regulate independently could exhibit reduced
expression in eomesamutant embryos while they might be complete-
ly silenced in eomesa-eng injected embryos. It is also possible that the
eomesa-eng construct interferes with the function of other highly
similar T-box genes. A strong candidate in this regard is eomesb, as
the T-domain of Eomesb is 88.2% identical to the Eomesa T-box and
eomesb has been reported to be expressed during early embryonic
stages (Takizawa et al., 2007). It will be interesting to determine
whether Eomesb has overlapping functions with Eomesa, which
could explain why the eomesa mutant phenotype is not stronger.
The other markermost affected in mutant embryos is og9x, which is
an immediate early gene in the Nodal pathway (Poulain and Lepage,
2002). Expression is barely detectable in mutant embryos similar to
what is observed in MZoep embryos (Poulain and Lepage, 2002). Pre-
vious work demonstrated that Eomesa overexpression enhances og9x
expression within its endogenous domain, providing further evidence
that Eomesa regulates it (Bjornson et al., 2005). Og9x appears to act in
a predominantly overlappingmanner with Bon and is not essential for
endoderm formation as morpholino knock-down in wild type em-
bryos has no detectable phenotype, presumably due to the contin-
ued expression of Bon (Poulain and Lepage, 2002).
Eomesa and Nodals
The Nodal pathway plays an essential role in endoderm speciﬁca-
tion in vertebrates (Zorn andWells, 2007). Nodal activated Smad pro-
teins associate with transcription factor partners to regulate gene
expression (Moustakas and Heldin, 2009). Work in both mouse and
frog indicates that Eomes can interact with Smad2/3 to regulate tar-
get gene transcription (Picozzi et al., 2009; Teo et al., 2011). Thus, it
seems likely that in zebraﬁsh Eomesa may also interact with Smads,
in addition to its interaction with Gata5 and Bon, to transduce Nodals
signals. In mouse, Nodals and Eomes interact genetically, though the
details of this interaction remain to be determined (Arnold et al.,
2008). Several observations suggest that in zebraﬁsh Eomesa might
have an additional role upstream of Nodals and thus potentially func-
tion in a feedback loop with them. We occasionally observed reduced
expression of ndr1 and ndr2 in MZeomesa mutant embryos and over-
expression of Eomesa weakly induces ndr1 expression (Bjornson
et al., 2005). Furthermore, Mxtx2 was recently shown to activate
ndr2 expression in the YSL (Hong et al., 2011). We also showed in
previous work that overexpression of Eomesa could induce ectopic
expression of the dorsal organizer genes gsc and ﬂh and that this re-
quires Nodal signaling (Bruce et al., 2003).
Putting it together: Maternal Control of Epiboly and Endoderm
Speciﬁcation
Several maternal effect mutants in zebraﬁsh play dual roles in
epiboly and endoderm patterning. MZspgmutant embryos completely
lack endoderm due to the failure to express sox17 (Reim et al., 2004),
while Eomesa appears to act earlier to activate og9x and regulate sox32
expression. Both MZspg and MZeomesa embryos also exhibit doming
delays and altered cell adhesion, but MZspg mutant embryos show
an additional epiboly progression delay, which is not observed in
MZeomesa embryos (Lachnit et al., 2008). Pou5f1 and Eomesa appear
to act independently to regulate epiboly and endoderm formation. In-
terestingly, a potential link in the regulation of the two genes has been
suggested by work on the mis/dhx16 mutant. mis mutant embryos
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epiboly, involution and convergent extension (Putiri and Pelegri,
2011). It has been suggested that Dhx16 might regulate Eomesa and
Pou5f1 activities post-transcriptionally (Putiri and Pelegri, 2011).
This intriguing link between epiboly and endoderm patterning war-
rants further investigation.
Conclusion
Our results indicate that maternal Eomesa plays a conserved role
in morphogenesis and endoderm patterning. Several maternal factors
are involved in regulating these two processes and it remains to be
seen the extent to which these factors function redundantly or in con-
cert to control early zebraﬁsh development. Furthermore, an open
question is whether there is a functional link between endoderm
speciﬁcation and epiboly. The eomesa mutant phenotype also reveals
for the ﬁrst time that aspects of epiboly initiation and progression are
separable. Additional studies of MZeomesa mutant embryos offer the
exciting possibility of gaining new insights into the molecular mech-
anisms governing epiboly initiation.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2011.10.036.
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